Lam Research Corporation $LRCX Position Increased by Pacer Advisors Inc.

Pacer Advisors Inc. boosted its position in shares of Lam Research Corporation (NASDAQ:LRCX) by 168.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 593,148 shares of the semiconductor company’s stock after purchasing an additional 372,195 shares during the period. Pacer Advisors Inc.’s holdings in Lam Research were worth $79,423,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the company. IMG Wealth Management Inc. acquired a new stake in shares of Lam Research during the 2nd quarter valued at about $26,000. Howard Hughes Medical Institute bought a new stake in Lam Research in the second quarter worth approximately $27,000. Sound Income Strategies LLC bought a new stake in Lam Research in the third quarter worth approximately $41,000. Strategic Wealth Investment Group LLC bought a new position in shares of Lam Research during the 2nd quarter valued at $29,000. Finally, Delos Wealth Advisors LLC acquired a new stake in shares of Lam Research in the 2nd quarter valued at $30,000. 84.61% of the stock is owned by institutional investors and hedge funds.

Lam Research Price Performance

Shares of NASDAQ:LRCX opened at $177.24 on Friday. The firm has a market capitalization of $222.62 billion, a PE ratio of 39.04, a PEG ratio of 2.05 and a beta of 1.77. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. The business’s 50 day moving average is $157.66 and its 200-day moving average is $125.34. Lam Research Corporation has a 1-year low of $56.32 and a 1-year high of $177.56.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, topping analysts’ consensus estimates of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The company had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.23 billion. During the same period last year, the firm earned $0.86 EPS. The firm’s revenue for the quarter was up 27.7% compared to the same quarter last year. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Sell-side analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be given a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Wednesday, December 3rd. Lam Research’s dividend payout ratio (DPR) is 22.91%.

Wall Street Analysts Forecast Growth

Several research firms have commented on LRCX. HSBC set a $127.00 target price on shares of Lam Research and gave the stock a “hold” rating in a research report on Tuesday, September 30th. JPMorgan Chase & Co. increased their price objective on Lam Research from $113.00 to $165.00 and gave the company an “overweight” rating in a report on Thursday, October 23rd. Needham & Company LLC boosted their target price on Lam Research from $150.00 to $160.00 and gave the stock a “buy” rating in a report on Thursday, October 23rd. Oppenheimer set a $200.00 target price on Lam Research and gave the stock an “outperform” rating in a research report on Thursday, October 23rd. Finally, Wall Street Zen lowered shares of Lam Research from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Twenty-six investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Lam Research presently has an average rating of “Moderate Buy” and an average target price of $161.21.

Insider Buying and Selling

In other Lam Research news, CFO Douglas R. Bettinger sold 40,080 shares of Lam Research stock in a transaction on Friday, November 14th. The stock was sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the completion of the transaction, the chief financial officer directly owned 987,237 shares of the company’s stock, valued at approximately $148,677,892.20. This trade represents a 3.90% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Bethany Mayer sold 1,298 shares of the business’s stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $159.99, for a total transaction of $207,667.02. Following the completion of the sale, the director owned 1,652 shares in the company, valued at $264,303.48. This represents a 44.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 102,608 shares of company stock worth $14,916,496 over the last 90 days. Corporate insiders own 0.31% of the company’s stock.

Trending Headlines about Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: AI-driven equipment demand is being cited as the main catalyst — recent reports say strong AI-related wafer fab orders lifted margins and the company narrative, supporting a multi-quarter revenue/earnings upgrade for Lam. Lam Research (LRCX) Is Up 7.4% After AI-Driven Equipment Demand Lifts Margins And Outlook Narrative
• Positive Sentiment: Analyst momentum and institutional research support (including a maintained buy from UBS) have helped lift sentiment and trading activity, contributing to intraday strength. UBS maintains Lam Research (LRCX) buy recommendation
• Positive Sentiment: Options volume and momentum signals spiked alongside analyst upgrades, amplifying short-term upside and helping push the stock to a new 52?week high. Lam Research Target of Unusually High Options Trading (NASDAQ:LRCX)
• Positive Sentiment: Multiple outlets are upgrading the long-term growth thesis — coverage highlights secular AI tailwinds, attractive margins and valuation re-rating potential as reasons to stay long-term bullish. Lam Research (LRCX): Assessing Valuation After AI-Driven Upgrades and Strong Wafer Fab Demand
• Neutral Sentiment: Reported short-interest data for late December appears unreliable/zero in the feeds; nothing actionable from these figures for now, so short-squeeze risk is unclear.
• Negative Sentiment: Delphi Management trimmed its stake (sold 4,149 shares, ~24.9% of its holding), a small institutional sell that could be viewed as a minor negative signal but is unlikely to alter the broader market view given the size. Delphi Management Inc. MA Sells 4,149 Shares of Lam Research Corporation $LRCX

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.